| |
| Issue |
Title |
| |
| No 1 (2008) |
ENDOCRINE TREATMENT OPTIONS FOR ADVANCED BREAST CANCER — THE ROLE OF FULVESTRANT |
Abstract
PDF (Rus)
|
|
J.F.R. Robertson, S.E. Come, S.E. Jones, L. Beex, M. Kaufmann, A. Makris, J.W.R. Nortier, K. Possinger, L.-E. Rutqvist |
| |
| No 1 (2008) |
СОВРЕМЕННЫЕ АСПЕКТЫ ПРИМЕНЕНИЯ ТАКСОТЕРА® ПРИ ДИССЕМИНИРОВАННОМ РАКЕ МОЛОЧНОЙ ЖЕЛЕЗЫ |
Abstract
PDF (Rus)
|
|
, , |
| |
| No 3-4 (2009) |
A COMBINATION OF TAXOTERE, DOXORUBICIN, CYCLOPHOSPHOMIDE IN ADJUVANT CHEMOTHERAPY OF OPERABLE BREAST CANCER GRANULOCYTE COLONY-STIMULATING FACTORS PRIMARY PROPHYLAXIS |
Abstract
PDF (Rus)
|
|
N. S. Besova, V. A. Gorbunova, I. V. Poddubnaya, N. P. Makarenko |
| |
| No 3-4 (2009) |
ARTIFICIAL MENOPAUSE AND EXPERIENCE OF CIMICIFUGA EXTRACT USE (KLIMADYNON) |
Abstract
PDF (Rus)
|
|
Yu. G. Payanidi, K. I. Zhordania |
| |
| No 1-2 (2009) |
IMPROVEMENT OF OVERALL SURVIVAL WITH PRIMARY BREAST CANCER WITH MICROMESTASES TO THE BONE MARROW BY ADJUVANT CLODRONATE THERAPY |
Abstract
PDF (Rus)
|
|
I.J. Diel, A. Jaschke, E. F. Solomayer, S. Golan, G. Bastert, S. Sohn, F. Schuetz |
| |
| No 1-2 (2009) |
ADJUVANT GOSERELIN IN PRE-MENOPAUSAL PATIENTS WITH EARLY BREAST CANCER: RESULTS FROM THE ZIPP STUDY |
Abstract
PDF (Rus)
|
|
M. Baum, A. Hackshaw, J. Houghtona, L. E. Rutqvist, T. Fornander, B. Nordenskjold, A. Nicolucci, R. Sainsburya |
| |
| No 1-2 (2009) |
ZOMETA IN COMPLEX TREATMENT FOR GENERALIZED BREAST CANCER: A CLINICAL CASE |
Abstract
PDF (Rus)
|
|
L. V. Bolotina |
| |
| No 1-2 (2009) |
CURRENT POTENTIALITIES OF THERAPY FOR FIBROCYSTIC DISEASE |
Abstract
PDF (Rus)
|
|
I. V. Vysotskaya |
| |
| No 1-2 (2009) |
TAXOTERE: UPDATE (REVIEW OF REPORTS AT THE 31st ANNUAL SYMPOSIUM ON BREAST CANCER (San Antonio, USA) |
Abstract
PDF (Rus)
|
|
M. B. Stenina |
| |
| No 4 (2010) |
Target approach to treating osseous system pathology |
Abstract
PDF (Rus)
|
|
M. B. Stenina, A. D. Petrova |
| |
| No 4 (2010) |
Role of ganaton in antiemetic therapy. New treatment capacities |
Abstract
PDF (Rus)
|
|
A. V. Snegovoy, L. V. Manzyuk |
| |
| No 4 (2010) |
Hormonal factors of virus-associated cancer of the cervix uteri |
Abstract
PDF (Rus)
|
|
O. N. Churuksayeva, O. N. Asadchikova, L. A. Kolomiyets, S. L. Stukanov, I. G. Vidyaeva, E. G. Nikitina, L. N. Urazova |
| |
| No 3 (2010) |
Prevention of bone metastases in breast cancer |
Abstract
PDF (Rus)
|
|
L. M. Kogonia |
| |
| No 3 (2010) |
Use of Mastodinon in different forms of mastopathy |
Abstract
PDF (Rus)
|
|
N. I. Rozhkova, E. V. Meskikh |
| |
| No 3 (2010) |
Vascular endothelial growth factor inhibitors in the treatment of ovarian cancer |
Abstract
PDF (Rus)
|
|
S. V. Khokhlova |
| |
| No 3 (2010) |
Erythropoietins (Epostim®) during chemoradiotherapy for malignancies in anemic patients |
Abstract
PDF (Rus)
|
|
V. A. Titova, Yu. M. Kreynina, A. N. Shipilova, L. N. Shevchenko, V. Yu. Petrovsky, I. V. Ose, T. F. Skobeleva, A. V. Akimov, A. L. Badmayev |
| |
| No 4 (2011) |
Drug treatment for metastatic breast cancer |
Abstract
PDF (Rus)
|
|
E. V. Artamonova |
| |
| No 1 (2012) |
Basic therapy in the treatment of diffuse fibrocystic mastopathy |
Abstract
PDF (Rus)
|
|
I. V. Vysotskaya |
| |
| No 1 (2012) |
Use of progestogel in diffuse forms of mastopathy |
Abstract
PDF (Rus)
|
|
E. V. Meskikh, N. I. Rozhkova |
| |
| No 2 (2012) |
Possibilities of hormonal therapy for diffuse dyshormonal dysplasia of the breast |
Abstract
PDF (Rus)
|
|
I. V. Vysotskaya |
| |
| No 2 (2012) |
First report of observation trial about impact of bisphosphonate`s treatment to the quality of life breast cancer patient with bone metastases |
Abstract
PDF (Rus)
|
|
O. V. Zelenova, L. V. Bolotina, L. Yu. Nikitina, M. V. Chernikov |
| |
| 1 - 21 of 21 Items |
|
